Dimerix Bioscience Pty Ltd
We contracted M2M to provide clinical support for the set-up of a Phase II study of a new treatment for kidney disease. We found M2M to be professional and organised in the provision of contracted activities. They were able to provide practical advice to support us during this phase, and we appreciated their responsiveness.
Molecule 2 Market
General Manager, Dimerix Bioscience Pty Ltd